Want to join the conversation?
$DHR 2Q15 Q&A: Steve of JPMorgan questions, any chance of closing Pall deal a little bit earlier than expected? Dan, CFO: Happy with how we're progressing in terms of various approvals, but again we don't know until we get the last one in. There is a decent chance this happens sooner this year, but until we get the last one, it is hard to forecast.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.